Proteomic analysis of exosomes derived from human lymphoma cells by Ye Yao et al.
EUROPEAN JOURNAL 
OF MEDICAL RESEARCH
Yao et al. European Journal of Medical Research  (2015) 20:8 
DOI 10.1186/s40001-014-0082-4RESEARCH Open AccessProteomic analysis of exosomes derived from
human lymphoma cells
Ye Yao†, Wei Wei†, Jing Sun, Linjun Chen, Xiaohui Deng, Liyuan Ma and Siguo Hao*Abstract
Background: Exosomes secreted by tumor cells contain specific antigens that may have immunotherapeutic purposes.
The aim of this study was to characterize the proteomic content of lymphoma cell-derived exosomes (LCEXs).
Methods: In this study, exosomes derived from Raji cells (EXORaji) were purified and proteins of EXORaji were separated
by one-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis. Protein bands were identified by mass
spectrometry. The protein components of EXORaji were analyzed using shotgun technology, and the function proteins
of EXORaji were defined and described using the Gene Ontology (GO) database and Kyoto Encyclopedia of Genes and
Genomes (KEGG) analysis.
Results: A total of 197 proteins were identified in EXORaji; 139 proteins were also identified in Raji cells, showing an
overlap of 70.56% of the total proteins in EXORaji. Interestingly, the remaining 58 proteins were unique to EXORaji.
The GO database and KEGG were used to define and describe the function of proteins. The data showed that some
important proteins involved in antigen procession and presentation as well as cell migration and adhesion were also
identified in EXORaji, such as MHC-I and II, HSC70, HSP90, and ICMA-1.
Conclusions: LCEXs express a discrete set of proteins involved in antigen presentation and cell migration and
adhesion, suggesting that LCEXs play an important role in the regulation of immunity and interaction between
lymphoma cells and their microenvironment. LCEXs harbor most of the proteins of lymphoma cells and could be
one of the sources of lymphoma-associated antigens for immunotherapeutic purposes.
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Mass spectrometryBackground
Tumor cells can release exosomes. Exosomes are a type
of vesicle secreted by late endosomes in eukaryotic cells
and loaded with cell membrane molecules, microRNAs,
and proteins [1-4]. Studies on the protein composition
of exosomes of dendritic cells (DCs) showed that loaded
proteins are mainly involved in regulation of cell physio-
logical activities [5-7]. Moreover, molecules involved in
antigen presentation such as major histocompatibility
complex (MHC)-I and MHC-II have also been detect-
able in DC-derived exosomes (DEXs) [6,7].
Although DEXs can induce antigen-specific antitumor
immunity, the biological characteristics of tumor cell-
derived exosomes (TEXs), especially those from lymphoma* Correspondence: haosghj88@hotmail.com
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unless otherwise stated.cells, remain unclear. Our previous studies and others
revealed that DEXs and TEXs can be taken up by DCs and
transfer tumor antigens to DCs in vitro and that TEX-
targeted DCs can induce stronger antigen-specific antitu-
mor immunity than TEXs alone [5,8-10]. These studies
collectively suggest that TEXs harbor tumor antigens and
are potential targets in the development of effective anti-
tumor vaccines [11,12].
Burkitt lymphoma (BL) is a highly aggressive B-cell
lymphoma with an extremely short cell doubling time
and usually presents in extranodal sites or as an acute
leukemia [13]. Here, BL tumor cells were chosen as a
model system to study the protein components of exo-
somes derived from human lymphoma cells because few
data are available on the protein components of exo-
somes derived from this tumor type.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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trophoresis and mass spectrometry (MS) enable us to
comprehensively study the protein composition of TEXs.
Our previous studies demonstrated that TEXs harbor
tumor cell-associated antigens and can induce tumor
antigen-specific antitumor immunity [5,10].
Similar to other tumor cells, lymphoma cells can release
exosomes [10]. However, the protein constituents of LCEXs
have still not been identified. In this study, proteins iso-
lated from EXORaji were separated by one-dimensional
SDS-PAGE, and protein bands were identified by mass
spectrometry. The protein components of EXORaji were
analyzed using shotgun technology. The GO database and




AIM-V serum-free conditioning medium, RPMI 1640
medium, and fetal bovine serum were purchased from
Invitrogen (Grand Island, Shanghai, China). Deuterium
oxide (D2O) was purchased from Tenglong Weibo
Technology (Qingdao, China). Sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) buffer
and 3-[(3-cholamidopropyl) dimethylamino]-1- propane-
sulfonate (CHAPS) were purchased from Sigma Aldrich
(Sigma Aldrich, Shanghai, China). TPCK-trypsin was pur-
chased from Promega (Promega, Shanghai, China). Aceto-
nitrile (GC purity) was purchased from Merck (Merck,
Shanghai, China). Lysis buffer, 4× separating gel buffer,
and balanced salt solution were sterilized by passing
through a 0.22-μm membrane filter before sub-packaging
and storing at −80°C.
Preparation of exosome purification
Raji cells were cultured in RPMI 1640 medium contain-
ing 10% inactivated fetal bovine serum at 37°C in a 5%
CO2 humidified incubator. After 24–72 h in serum-free
conditioned medium, cell viability was >95% as deter-
mined by a trypan blue exclusion assay. Exosomes were
prepared as previously described [10,14]. The super-
natant was centrifuged at a series of successively lower
forces to remove cells and cellular debris. The resultant
clarified supernatant was concentrated by centrifugation
at 100,000 g at 4°C for 60 min. The pellets were washed
with 0.01 M phosphate-buffered saline, transferred to a
10-ml ultracentrifuge tube underlaid with a 1.5-ml 30%
sucrose/D2O density cushion (density: 1.210 g/cm
3), and
ultracentrifuged (Beckman Coulter, Shanghai, China) at
100,000 g at 4°C for 1 h. Finally, the exosomes were con-
centrated by centrifugation at 1,000 g for 60 min in a
pre-rinsed 100-kDa molecular weight Ultra capsule filter
(Millipore, Billerica, Shanghai, China). The concentra-
tion of exosomal proteins was determined using a QuickStart™ Bradford Protein Assay Kit (Bio-Rad®, Shanghai,
China). The exosomes were stored at −80°C until use.Morphological characteristics of EXORaji
Exosomes derived from Raji cells (10 μg) were washed
in cacodylate buffer, fixed in 2.5% glutaraldehyde (Poly-
sciences, Shanghai, China) in cacodylate buffer overnight
at 4°C, dehydrated by graded alcohol processing, and flat
embedded in LX-112 epoxy resin. Sections were cut with
an ultramicrotome. Mounted sections were collected on
copper grids, stained with a saturated solution of uranyl
acetate, and submitted for observation and imaging under
a Philips CM12 transmission electron microscope (TEM)
(Philips, Shanghai, China) [15]. To characterize the exo-
somes, ER-residing molecules such as ER-residing protein
Grp94 in exosomes derived from Raji cells were examined
by Western blot.Two-dimensional SDS-PAGE
Isoelectronic focusing (IEF) was performed with 18-cm
immobilized strips with pH values from 3–10 and 4–9 in
an IPGphor electrophoresis device (Amersham Bioscience,
Shanghai, China). Briefly, samples of EXORaji and Raji cells
were diluted into 350 ml buffer and loaded onto an IPG
strip. IEF was carried out at 20°C according to the follow-
ing schedule: 12 h at 30 V, 2 h at 100 V, 1 h at 500 V, 1 h
at 1,000 V, 1 h of a linear gradient to 8,000 V, and 10 h at
8,000 V. After IEF, the strips were equilibrated in 6 M urea,
30% glycerol, 2% SDS, and 50 mM Tris-HCl (pH 6.8) con-
taining 1% 1,4-dithiothreitol for 15 min followed by 2.5%
(w/v) iodoacetamide. The strips were transferred onto
the gel and sealed in place with 1% agarose. The two-
dimensional SDS-PAGE was performed using 12% poly-
acrylamide gels at 20 mA and 16 V on Bio-Rad Protein
II (Bio-Rad, Shanghai, China) and was terminated when
the bromophenol blue front had migrated to the lower
end of the gels. The gels were then stained with silver
[16] and scanned by the ImageScanner (Amersham
Pharmacia, Shanghai, China).One-dimensional protein electrophoresis
One-dimensional electrophoresis of EXORaji on 10%
SDS-PAGE gels was performed according to the man-
ufacturer’s instructions (BioRad Laboratories, Shanghai,
China). Then 10 μg of each sample was taken up in
8 M urea, 2% CHAPS, 20 mM dithiothreitol, and
0.01% bromophenol blue and transferred onto 1.0-mm-
thick 10% SDS-PAGE gels. A constant current of 7 mA
per gel was applied at 10°C. After 16 h, the gels were
stained using the Novex Colloidal Blue Staining Kit ac-
cording to the manufacturer’s instructions (Invitrogen,
Shanghai, China).
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Stained electrophoresis gels loaded with Raji cells and
EXORaji were excised into four parts and submitted for
enzymatic digestion. Proteins were first enzymolyzed
into peptides. Enzymatic digestion of proteins in the gels
was performed as previously described [14]. Briefly, the
Ettan™ MDLC system (GE Healthcare, Shanghai, China)
was used to desalt and separate the tryptic peptides mix-
tures. In this system, samples are desalted on reversed
phase (RP) trap columns (Agilent Technologies, Shanghai,
China) and subsequently separated on RP columns
(Column Technology Inc., Shanghai, China). Mobile
phase A (0.1% formic acid in HPLC-grade water) and
mobile phase B (0.1% formic acid in acetonitrile) were
selected. The tryptic peptide mixture (20 μg) was loaded
onto the column, and separation was performed at a flow
rate of 2 μl/min with a linear gradient of 4–50% B for
120 min. A Finnigan LTQ™ linear ion trap MS (Thermo
Electron, Shanghai, China) equipped with an electrospray
interface was connected to the LC setup to detect eluted
peptides. Data-dependent MS/MS spectra were obtained
simultaneously. Each scan cycle consisted of one full MS
scan in the profile mode followed by five MS/MS scans in
the centroid mode with the following Dynamic Exclusion™
settings: repeat count: 2; repeat duration: 30 s; exclusion
duration: 90 s. Each sample was analyzed in triplicate.
Mass spectrometry data acquisition and analysis
MS/MS spectra were automatically searched against the
non-redundant International Protein Index human pro-
tein database (version 3.26, 67 687 entries) using the
Bioworks Browser 3.1. The peptides were constrained to
be tryptic, and up to two missed cleavages were allowed.
Carbamidomethylation of cysteines was treated as a fixed
modification, whereas methionine residue oxidation was
considered a variable modification. The mass tolerances
allowed for precursor and fragment ions were 2.0 and
0.0 Da, respectively. The protein identification criteria
were based on Delta CN (≥0.1) and cross-correlation
scores (Xcorr, one charge ≥1.9; two charges ≥2.2; three
charges ≥3.75).
Western blotting
Western blotting was performed following one-dimensional
SDS-PAGE as follows. Protein samples from EXORaji
and Raji cells were electroblotted onto Immobilon P
membranes (Millipore Corp, Shanghai, China) and incu-
bated with specific antibodies, followed by horseradish
peroxidase-conjugated secondary antibodies, and detected
using SuperSignal West Pico chemiluminescent substrate
(Pierce Perbio Science, Shanghai, China). Antibodies used
in this study to confirm the proteins detected by MS were:
anti-HSC70 (clone 13D3; Thorma Scientific, Shanghai,
China), anti-ICAM-1 (clone 9H21L19; Thorma Scientific,Shanghai, China), and anti-actin (clone 15G5A11/E2,
Thorma Scientific, Shanghai, China).
Results
Morphology of exosomes derived from lymphoma cells
We first assessed whether exosomes derived from Raji
cells were similar to those released by other tumor cell
lines. The supernatant was centrifuged at up to 100,000
g, and the pellet was similar to previously reported exo-
somes, as determined by electron microscopy [17]. The
vesicles were <100 nm in diameter and had a dimpled,
cup-shaped morphology, characteristic of exosomes (see
Figure 1a). To characterize EXORaji, we also examined
the presence of the ER-residing protein Grp94 by Western
blot. Data showed that Grp94 was absent in EXORaji (see
Figure 1b). Taken together, these results indicate that vesi-
cles obtained from cell-free supernatants of Raji lymph-
oma cells exhibit characteristic biophysical properties of
exosomes.
Mass spectrometric analysis of proteins in EXORaji
Protein samples were then separated by one-dimensional
SDS-PAGE for further MS analysis. The gels were stained
with Coomassie Blue R-250, and protein bands were
digested for capillary high-performance liquid chroma-
tography analysis. As shown in Figure 1, protein bands
showed similar patterns between the preparations from
EXORaji and Raji cells. Two-dimensional electrophoresis
was also used to compare the protein contents from
EXORaji and Raji cells (see Figure 2). Although the protein
spots of EXORaji were slightly less than those of the Raji
cells, more than 70% of the protein spots in Raji cells were
also found in EXORaji. To further explore the proteomic
characteristics of EXORaji, EXORaji samples were separated
by one-dimensional SDS-PAGE for further MS analysis,
the base peak maps of Raji cells and EXORaji were collec-
ted according to the mass-to-charge ratios of the peptides
and peptide fragments.
All collected base peak data were analyzed by DeCyder
MS and BuildSummary 4.9.0 software to output all iden-
tified proteins. According to shotgun protein identifica-
tion, 322 proteins were identified in Raji cell samples,
while 197 proteins were identified in EXORaji. Among
the proteins in EXORaji samples, 139 were identified in
both samples, showing an overlap of 70.56% of the total
proteins in EXORaji samples, indicating that more than
70% of proteins in EXORaji were derived from their
parental cells. Interestingly, the remaining 58 proteins,
accounting for about 30% of proteins in EXORaji, were
not identified in Raji cells, indicating that some proteins
in EXORaji may be obtained from the extracellular mi-
croenvironment or enriched in the process of exosome
development (see Figure 3). Most of these proteins are a
composition of HLA class I and II molecules, such as
50nm
EXORaji Raji cells




Figure 1 Morphology of EXORaji and one-dimensional electrophoresis of samples from EXORaji and Raji cells. a. Transmission electron
microscope image of EXORaji (×100 K). b. Western blot analysis demonstrating the absence of Grp94 in EXORaji. c. Protein samples from EXORaji
and Raji cells were separated by SDS-PAGE for further MS analysis. Lanes 1 and 2 represent Raji cell-derived exosomes, and lanes 3 to 6 represent
Raji cells.
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chain, B-39 alpha, A-26 alpha China, HLA-DQA1 MHC
class II antigen, HLA class II histocompatibility antigen,
DQ(1) beta China, HLA-C antigen, Cw-4 alpha and Cw-3
alpha chain, HLA-DPB1 major histocompatibility com-
plex, class II, DP beta1, CD81, CD82 antigen and inter-
cellular adhesion molecule 1, etc. These proteins play an
important role in antigen processing and presentation and
regulation of cell interactions.
Analysis of protein function in EXORaji using GO analysis
Next, we analyzed the function of proteins in EXORaji
according to the biological process, molecular function,
and cell components with GO analysis. As shown in
Table 1, among the 139 proteins in EXORaji, 46.7% and
43.2% were involved in localization and establishment of
localization, respectively; 41.7% of the proteins were
involved in response to stimulus, 38.1% of the proteins
were involved in cellular component organization, andmore than 20% of proteins were involved in immune
system processes. Similarly, among 58 proteins unique
to EXORaji, more than 30% were involved in localization,
establishment of localization, and response to stimulus
(see Table 2), indicating that LCEX plays an important
role in biological process including response to stimuli
and establishment of localization. In terms of molecular
function, all proteins identified in EXORaji were involved
in protein binding, more than 45% of which were involved
in nucleotide binding, and 20% were involved in nucleo-
side binding and hydrolase activity. Similarly, more than
60% of the proteins unique to EXORaji were involved in
protein binding (Table 2), suggesting that LCEX plays an
important role in protein binding.
Other and our previous studies have demonstrated
that exosomes may harbor proteins and associated anti-
gens of their parental cells [5,10,18,19]. In this study, more
than 90% of the proteins in EXORaji were involved in






Figure 2 Two-dimensional electrophoresis of samples from Raji
cells (a) and EXORaji (b).
Raji cells
183 139 70.56% 58
EXORaji
Figure 3 Distribution of identified proteins in Raji cells and
EXORaji. Shotgun protein identification reveals 322 proteins in Raji
cell samples (white) and 197 in EXORaji samples (gray); 139 proteins are
identified in both samples, accounting for 70.56% of the total identified
proteins in EXORaji samples, while the remaining 58 proteins are unique
to EXORaji.
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mately 47% of proteins were involved in intracellular or-
ganelle components and organelle components. Among
the proteins uniquely identified in EXORaji, more than
40% were involved in the membrane and membrane com-
ponents. Taken together, these data suggest that LCEX isinvolved in various biological activities associated with
biological processes, molecular functions, and cellular
components, which provides further evidence that LCEXs
harbor intracellular and membrane proteins from their
parental cells.
KEGG pathway analysis
The KEGG provides an operating platform based on the
building blocks of genome information (i.e., GENES) and
chemical substance information (i.e., LIGAND), linking
the genome to biological systems via metabolic networks
(i.e., PATHWAY), subsequently categorizing proteins ac-
cording to the functional level (i.e., BRITE) [20]. In this
study, KEGG pathway analysis was used to analyze the
proteins identified in EXORaji. We found that 12 proteins
identified in EXORaji are involved in antigen process-
ing and presenting, such as PA28, heat shock protein
(HSP) 70 and 90, MHC-I, T-cell receptor, and killer-cell
immunoglobulin-like receptor (see Figure 4a). Ten
proteins in EXORaji are involved in several metabolic
pathways such as glycolysis/gluconeogenesis, and eight
proteins are involved in cell adhesion (see Figure 4b).
Western blotting also confirmed the presence of HSP 70
and ICAM-1 in EXORaji (see Figure 5). Taken together,
our data indicate that LCEXs harbor some immunological
and adhesion molecules and may play an important role
in immune regulation and cell adhesion.
Discussion
To date, tumor exosomes have not yet been character-
ized. While much is known about dendritic cell-derived
Table 1 Categories of proteins identified in Raji cells and EXORaji by GO analysis
Biological process Molecular function
E&R EXORaji Raji cells E&R EXORaji Raji cells
Response to stimulus 45 60 108 Hydrolase activity 39 43 82
Immune system process 18 32 16 Nucleoside binding 40 42 91
Cell killing 3 3 3 Nucleotide binding 58 60 143
Localization 46 65 77 Protein binding 105 139 250
Multi-organism process 11 20 25 Nitric-oxide synthase regulator activity 2 2 2
Establishment of localization 43 62 74 Proteasome activator activity 2 2 2
Cellular component organization 44 57 86 Nucleobase binding 2 2 3
Cellular component biogenesis 23 27 58 Cell surface binding 4 5 4
Cell component Carboxylic acid binding 5 5 7
E&R EXORaji Raji cells Translation factor activity 5 5 10
Ribonucleo protein complex 8 10 61 Lyase activity 8 8 11
Protein complex 47 52 98 Cofactor binding 9 9 15
Organelle lumen 24 24 100
Non-membrane bounded 45 51 113
Organelle part 52 56 162
Intracellular organelle 86 105 241
Intracellular part 107 139 292
Organelle membrane 14 17 33
Vesicle 24 32 34
Organelle envelope 11 14 34
The protein constituents of Raji cell and EXORaji were analyzed by GO software according to the biological pathways, molecular function, and cell components.
Table 1 shows the analysis results. The numbers of protein kinds presented in each sample or in both samples were listed.
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characterization of LCEXs. In this study, exosome-like
vesicles were isolated from the culture supernatant of
the Raji lymphoma cell line through successive centrifu-
gation. Electron microscopy showed vesicles measuring
60–150 nm in diameter. Western blot revealed the ab-
sence of ER-residing protein Grp94 in EXORaji, while
acetyl cholinesterase activity was detectable in EXORaji.
Taken together, these data indicate that vesicles ob-
tained from cell-free supernatants of Raji lymphoma
cells exhibit similar biophysical properties to those of
exosomes.Table 2 Category of proteins uniquely identified in EXORaji by
Molecular function Biological process
Pattern binding 3 Reproduction
Carbohydrate binding 6 Reproductive process
Signal transducer activity 14 Immune system proce




The protein constituents of 58 kinds of proteins unique to EXORaji were analyzed by
cell components. Table 2 shows the analysis results. The numbers of proteins preseMass spectrometry is a classical method in proteomics
that facilitates the identification of complex protein pro-
files. This technique requires small samples but outputs
data of high resolution with high detection sensitivity
[21]. In this study, MS was used to analyze the protein
components of EXORaji and to determine the differences
and similarities of protein components between Raji
cells and EXORaji to investigate the functional role of
EXORaji proteins. More than 70% of proteins in EXORaji
were derived from its parental Raji cells, consistent with
the data from two-dimensional electrophoresis. These
data indicate that LCEXs harbor the majority of proteinsGO analysis
Cell component
9 Protein-lipid complex 3
9 Protein complex 13
ss 11 Cell surface 5
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Figure 4 KEGG analysis in EXORaji reveals proteins involved in antigen processing and presenting (a) and cell adhesion (b). KEGG used
for pathway analysis of proteins expressed in EXORaji shows 12 proteins involved in antigen processing and presenting and eight proteins involved in
cell adhesion. Indicated molecules are marked with stars.
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Figure 5 The presence of actin, HSP70 (a), and ICAM-1 (b) is
confirmed by Western blot analysis of EXORaji. The primary
antibodies were anti-actin (1:10,000) and anti-HSP70 (1:1,000),
followed by horseradish peroxidase-conjugated goat anti-mouse IgG1.
Blots were incubated with SuperSignal West Pico chemiluminescent
substrate and exposed to Hyperfilm ECL (Amersham Biosciences,
Shanghai, China).
Yao et al. European Journal of Medical Research  (2015) 20:8 Page 8 of 10derived from the cellular components of their parental
cells. Meanwhile, we also demonstrated that some of
surface molecules of Raji cells, such as CD19, CD20, and
CD22, also were identified in EXORaji. These surface
molecules of Raji cells are not only surface antigens, but
also are targets of treatment; for example, rituximab, an
anti-CD20 antibody, has been widely used in the treat-
ment of adult Burkitt and Burkitt-type lymphoma or
acute lymphoblastic leukemia [22]. Previous and our
studies have shown that exosomes derived from mouse
tumors contain a large proportion of tumor antigens
and MHC class I molecules loaded with tumor peptides
[9,10,23]; these studies have demonstrated that tumor cell-
derived exosomes could induce tumor antigen-specific
antitumor immunity. Taken together, we speculate that
LCEXs may be a potential source of lymphoma cell-
associated antigens for immunotherapy. However, 58
proteins were uniquely identified in EXORaji, indicating
that some proteins may be enriched in LCEXs and ac-
quired from the extracellular microenvironment. LCEXs
may play a role in antigen processing and presentation
and regulation of cell interactions since most of the pro-
teins in EXORaji are composed of HLA class I and II
molecules and CD81, CD82, and intercellular adhesion
molecule-1.
Few studies have described the functions of proteins in
LCEXs. To the best of our knowledge, this is the firststudy to demonstrate that EXORaji-derived proteins are
involved in many biological activities such as response
to stimuli, establishment of localization, and protein
and nucleotide binding. Because the LCEX vesicle is
mainly formed in the cell lumen, it contains the lar-
gest proportion of protein molecules involved in the
formation of intracellular components including organelle
components such as the organelle lumen. In addition,
such structures contain the majority of proteins involved
in the formation of intracellular components.
The KEGG provides an operating platform based on
the building blocks of genome information and chemical
substance information, subsequently categorizing pro-
teins according to the functional level. In this study, the
KEGG database was used to identify the detected pro-
teins, revealing that eight of the proteins found in LCEX
were cell adhesion molecules (CAMs), mainly ICAM
and MHC molecules, while 12 proteins were involved in
antigen processing and presenting, belonging to the heat
shock cognate protein (HSP)70 and HSP90 family and
PA28. These molecules had higher credibility in the
identification of proteins loaded on LCEX; ICAM-1 and
HSP70 indeed presented in LCEX according to our
Western blotting results. Consistent with our findings,
Thery et al. suggested that exosomes contain HSP70,
while Nylandsted et al. reported the expression of HSP70
in endosome-lysosomal compartments [7,24]. HSPs are a
group of common proteins that play a role in the cell
response to elevated temperature, infection, cytokine
stimulation, and other environmental stresses. HSPs are
normally present in small amounts within the cytoplasm
of all cells in all life forms, but can also be released into
the extracellular environment in the absence of cellular
necrosis [25]. The precise mechanisms by which HSPs are
actively released by viable cells have not yet been eluci-
dated, but we propose that exosomes play a role in releas-
ing HSPs from cells. Inside cells, HSPs are involved in
protein trafficking, whereby they regulate the proper fold-
ing of other proteins, maintain their correct and func-
tional shape, and transport them from one location to
another [26]. These proteins thus act as chaperones,
bringing along with them small fragments or peptides de-
rived from other proteins expressed in the cell, providing
a “fingerprint” of the cell’s content [27]. Therefore, exo-
somes carrying large amounts of HSPs from tumor cells
may be optimal candidates for cancer immunotherapy
without the need to identify the antigens themselves. In
vivo, HSPs in exosomes can be taken up by DCs and mac-
rophages via CD91 receptor-mediated endocytosis [28,29]
and then processed for presentation to the immune sys-
tem in lymph nodes. Tumor-specific antigens are released
from the HSP inside the cell and presented to cytotoxic T
cells (CTL), or “killer cells”, which are then activated.
Many studies have shown that immune cells stimulated
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cells [30-33].
While intercellular adhesion molecule-1 (ICAM-1) is a
transmembrane protein, two types of extracellular ICAM-1
have been detected in cell culture supernatants as well as
in the serum: a soluble form of ICAM-1 (sICAM-1) and a
membranous form of ICAM-1 (mICAM-1) associated with
exosomes. Previous observations have demonstrated that
sICAM-1 cannot exert potent immune modulatory activity
because of its low affinity for leukocyte function-associated
antigen-1 (LFA-1) or membrane attack complex-1. A
previous study has demonstrated that mICAM-1 on
exosomes retained its topology similarly to that of cell
surface ICAM-1 and could bind to leukocytes, indicating
that mICAM-1 on exosomes exhibits potent immuno-
modulatory activity [34]. Other studies and our previous
one also demonstrated that exosomes loaded with tumor
antigen can be taken up by dendritic cells (DCs) and
transfer tumor antigen to DCs in vitro; activated T cells
also can recruit dendritic cell-derived exosomes via
LFA-1. Taken together, LFA-1/ICAM-1 interactions
play an important role in exosome uptake by antigen-
presenting cells and T cells [5,35].
PA28, an 180,000-Da protein, is a proteasome activator
that is strongly induced by the major immunomodula-
tory cytokine IFN-γ [36,37] and has been implicated in
the regulation of MHC class I Ag processing [16]. PA28
may accelerate the production of MHC class I ligand
from longer precursor peptides by the 20S proteasome
in vitro [38], regulate the proteasome’s hydrolysis of
small nonubiquitinated peptides as a positive allosteric
effector, and modulate the proteasome-catalyzed pro-
duction of antigenic peptides presented to the immune
system on MHC class I molecules [16,39]. Therefore, we
hypothesized that HSC70 and CAMs presented by LCEX
may promote the combination, endocytosis, and intern-
alization of LCEX into APCs in a receptor-mediated
manner, thereby enhancing immune responses.Conclusion
In conclusion, LCEXs express a discrete set of proteins
involved in antigen presentation, signal transduction, and
adhesion and thereby may provide an important pathway
in the communication between cells. On the other hand,
LCEXs harbor most of proteins expressed in their parental
lymphoma cells and may be a potential source of lymph-
oma cell antigens for immunotherapy.
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